Results 121 to 130 of about 4,953 (173)

A Rare Case of Pyoderma Gangrenosum Pointing to Waldenström Macroglobulinemia. [PDF]

Case Rep Oncol Med
Krishnan L, Vachon E, Mishra A, McCoy D.
europepmc   +1 more source

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia. [PDF]

Blood
Sun H, Sklavenitis-Pistofidis R, Liu S, Liu X, Tsakmaklis N, Hatcher JM, Guerrera ML, Kofides A, Ramirez-Gamero A, Peachey AL, Li S, Keskin DB, Chea V, Kim N, Lyu H, Lu W, Livak KJ, Meid K, Guijosa A, Flynn CA, Pizzarella D, Patterson CJ, Hao M, Yi S, Yuan W, Branagan AR, Wu CJ, Ghobrial IM, Qiu L, Sarosiek SR, Castillo JJ, Hunter ZR, Treon SP.   +32 more
europepmc   +1 more source

Cutaneous macroglobulinosis with Waldenström macroglobulinemia

JAAD Case Reports, 2020
Hussein M.M. Hassab-El-Naby, MD, Mohamed El-Khalawany, MD, Mahmoud A. Rageh, MSc   +2 more
doaj   +1 more source

UVEAL EFFUSION IN WALDENSTRÖM MACROGLOBULINEMIA: A CASE REPORT. [PDF]

Retin Cases Brief Rep
Darmon J, Anjou M, Georgelin D, Brezin AP, Bremond-Gignac D.   +4 more
europepmc   +1 more source

Transformation and survival in patients with Waldenström macroglobulinemia: a population-based study. [PDF]

Discov Oncol
Du Y, Chang X, Li X, Xing S.
europepmc   +1 more source

Optimizing treatment for Waldenström macroglobulinemia-associated acquired von Willebrand syndrome: a case report and literature review. [PDF]

Front Oncol
Shen K, Yang C, Ma H.
europepmc   +1 more source

Impact of baseline osseous involvement on outcomes in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. [PDF]

Blood Neoplasia
Sharp J, Bhatta S, Takacs N, Tong K, Youssef Y, Bond DA, Sawalha Y, Sigmund A, Alinari L, Baiocchi R, Maddocks K, Christian B, Voorhees TJ, Epperla N.   +13 more
europepmc   +1 more source

Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia. [PDF]

Blood Adv
Ramirez-Gamero A, Tsakmaklis N, Hunter ZR, Guerrera ML, Guijosa A, Sarosiek S, Treon SP, Castillo JJ.   +7 more
europepmc   +1 more source

Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study. [PDF]

Blood Adv
Autore F, Tedeschi A, Benevolo G, Danesin N, Giannarelli D, Rizzi R, Cencini E, Mattiello V, Ferrarini I, Pasquale R, Del Giudice I, Ferrari A, Bullo M, Rossini B, Motta M, Marino D, Innocenti I, Stirparo L, Petrilli D, Musto P, Peri V, Zamprogna G, Hohaus S, Frustaci AM, Piazza F, Ferrero S, Laurenti L.   +26 more
europepmc   +1 more source

Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia. [PDF]

Discov Oncol
Danesin N, Leone G, D'Antiga M, Scapinello G, Carraro M, Cellini A, Angotzi F, Zoletto S, Bonaldi L, Vianello F, Manni S, Pizzi M, Visentin A, Trentin L, Piazza F.   +14 more
europepmc   +1 more source